The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Ophthalmic Drug Dosage Forms: Characterisation and Research Methods
Open accessAbstract
This paper describes hitherto developed drug forms for topical ocular administration, that is, eye drops, ointments,in situ gels, inserts, multicompartment drug delivery systems, and ophthalmic drug forms with bioadhesive properties. Heretofore, many studies have demonstrated that new and more complex ophthalmic drug forms exhibit advantage over traditional ones and are able to increase the bioavailability of the active substance by, among others, reducing the susceptibility of drug forms to defense mechanisms of the human eye, extending contact time of drug with the cornea, increasing the penetration through the complex anatomical structure of the eye, and providing controlled release of drugs into the eye tissues, which allows reducing the drug application frequency. The rest of the paper describes recommended in vitro and in vivo studies to be performed for various ophthalmic drugs forms in order to assess whether the form is acceptable from the perspective of desired properties and patient’s compliance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0073-2 · Cited by 1,885 · cited 1×
“NTA exhibits more precision in size distribution in comparison to DLS but requires larger volume of the sample (about 300 μL) [57, 69].”
BackgroundInternational Conference on Harmonisation
Guy, R. C. (2014) · Encyclopedia of Toxicology · doi:10.1016/b978-0-12-386454-3.00861-7 · Cited by 1,478
Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products
(2009) · Handbook of Pharmaceutical Manufacturing Formulations · doi:10.3109/9781420081244-13 · Cited by 1,313
Drug Development and Industrial Pharmacy
Rhodes, C. T. (1995) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049509070870 · Cited by 1,263
Mucoadhesive drug delivery systems
Donnelly, R., Shaikh, R., Raj Singh, T., Garland, M., & Woolfson, A. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.76478 · Cited by 740
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Nanotechnology in ocular drug delivery
Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.021 · Cited by 510
Polymeric nanoparticulate system: A potential approach for ocular drug delivery
Nagarwal, R. C., Kant, S., Singh, P. N., Maiti, P., & Pandit, J. K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.018 · Cited by 481
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21079 · Cited by 452
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
de Campos, A. M., Diebold, Y., Carvalho, E. L. S., Sánchez, A., & José Alonso, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026432.75781.cb · Cited by 404
Vandamme, T. F., & Brobeck, L. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 401
Wilhelmus, K. R. (2001) · Survey of Ophthalmology · doi:10.1016/s0039-6257(01)00211-9 · Cited by 385
Nanotechnology in Ocular Drug Delivery
Patel, D., Pathak, D., & Giradkar, P. (2021) · Nanocarriers: Drug Delivery System · doi:10.1007/978-981-33-4497-6_18 · Cited by 362
Jung, H. J., Abou-Jaoude, M., Carbia, B. E., Plummer, C., & Chauhan, A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.010 · Cited by 256
Iontophoresis: A non-invasive ocular drug delivery
Eljarrat-Binstock, E., & Domb, A. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.049 · Cited by 216
(1989) · Elsevier eBooks · doi:10.1016/c2013-0-06552-8 · Cited by 181
Desai, S. D., & Blanchard, J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970090e · Cited by 177
Giannavola, C., Bucolo, C., Maltese, A., Paolino, D., Vandelli, M. A., Puglisi, G., Lee, V. H. L., & Fresta, M. (2003) · Pharmaceutical Research · doi:10.1023/a:1023290514575 · Cited by 176
Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye
Loftsson, T., & Stefánsson, E. (2002) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2002.800205.x · Cited by 173
Extended cyclosporine delivery by silicone–hydrogel contact lenses
Peng, C.-C., & Chauhan, A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.028 · Cited by 147
Ocular drug delivery system: a reference to natural polymers
Pahuja, P., Arora, S., & Pawar, P. K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.690733 · Cited by 136
Kapoor, Y., & Chauhan, A. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.05.028 · Cited by 134
Aburahma, M. H., & Mahmoud, A. A. K. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9701-3 · Cited by 133
Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations
Budai, L., HAJDU, M., Budai, M., Gróf, P., Béni, S., Noszál, B., Klebovich, I., & Antal, I. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.013 · Cited by 128
Ocular drug delivery: a clue from nanotechnology
Bucolo, C., Drago, F., & Salomone, S. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00188 · Cited by 125
Protein Particulate Detection Issues in Biotherapeutics Development—Current Status
Das, T. K. (2012) · AAPS PharmSciTech · doi:10.1208/s12249-012-9793-4 · Cited by 124
Yamaguchi, M., Yasueda, S.-I., Isowaki, A., Yamamoto, M., Kimura, M., Inada, K., & Ohtori, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.036 · Cited by 100
Averineni, R. K., Shavi, G. V., Gurram, A. K., Deshpande, P. B., Arumugam, K., Maliyakkal, N., Meka, S. R., & Nayanabhirama, U. (2012) · Bulletin of Materials Science · doi:10.1007/s12034-012-0313-7 · Cited by 96
Boone, A. N., Hui, A., & Jones, L. (2009) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/icl.0b013e3181b26c49 · Cited by 80
Nanoliposomal minocycline for ocular drug delivery
Kaiser, J. M., Imai, H., Haakenson, J. K., Brucklacher, R. M., Fox, T. E., Shanmugavelandy, S. S., Unrath, K. A., Pedersen, M. M., Dai, P., Freeman, W. M., et al. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.004 · Cited by 69
NANOTECHNOLOGY: A NEW APPROACH FOR OCULAR DRUG DELIVERY SYSTEM
Mudgil, M., Gupta, N. M., Nagpal, M., & Pawar, P. K. (2012) · Cited by 68
Prodrugs for improved ocular drug delivery
Järvinen, T., & Järvinen, K. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00107-i · Cited by 62
COMPARATIVE REVIEW ON CONVENTIONAL AND ADVANCED OCULAR DRUG DELIVERY FORMULATIONS
Arul, K. S. G., Karthika, K., & Padmapreetha, A. J. (2010) · Cited by 58
DENDRIMER: A NOVEL DRUG DELIVERY SYSTEM
Mishra, I. (2011) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v1i2.46 · Cited by 54
The concept of ocular inserts as drug delivery systems: An overview
Deivasigamani, K., Bhowmick, M., Pandey, V. P., et al. (2008) · Asian Journal of Pharmaceutics · doi:10.4103/0973-8398.45031 · Cited by 38
Dendrimers: A Tool for Drug Delivery
Malik, A., Chaudhary, S., Garg, G., & Tomar, A. (2012) · Cited by 34
A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye
Moosa-Battey, R., Choonara, Y. E., du Toit, L. C., Kumar, P., Carmichael, T. R., Tomar, L. K., Tyagi, C., & Pillay, V. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12131 · Cited by 32
The concept of ocular inserts as drug delivery systems: An overview
Deivasigamani, K., Bhowmick, M., Pandey, V. P., et al. (2008) · Asian Journal of Pharmaceutics · doi:10.22377/ajp.v2i4.204 · Cited by 20
Some studies into the properties of indomethacin suspensions intended for ophthalmic use
Vulovic, N., Primprac, M., Stupar, M., et al. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90032-x · Cited by 17
Development of Acyclovir-loaded Bovine Serum Albumin Nanoparticles for Ocular Drug Delivery
Noomwong, P., Ratanasak, W., Polnok, A., & Sarisuta, N. (2012) · International Journal of Phytomedicine · Cited by 7
Cited by
Thin films as an emerging platform for drug delivery
Karki, S., Kim, H., Na, S.-J., Shin, D., Jo, K., & Lee, J. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.05.004 · Cited by 543
Gaballa, S. A., Kompella, U. B., Elgarhy, O., Alqahtani, A. M., Pierscionek, B., Alany, R. G., & Abdelkader, H. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00843-z · Cited by 255
Micelles: promising ocular drug carriers for anterior and posterior segment diseases
Durgun, M. E., Güngör, S., & Özsoy, Y. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0109 · Cited by 67
Ch, S., Padaga, S. G., Ghosh, B., Roy, S., & Biswas, S. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120822 · Cited by 40
RetractedPescina, S., Grolli Lucca, L., Govoni, P., Padula, C., Del Favero, E., Cantù, L., Santi, P., & Nicoli, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090476 · Cited by 38
“While the pH of TP and P formulations was higher than 4, acceptable for ocular instillation [63], it was necessary to increase the pH of T (3.”
Background
Metadata
- Authors
- Baranowski, P., Karolewicz, B., Gajda, M., & Pluta, J.
- Venue
- The Scientific World Journal
- Publisher
- Hindawi Limited
- Published
- 2014
- Volume
- 2014
- Pages
- 1-14
- ISSN
- 1537-744X (ISSN-L)
- 2356-6140
- OpenAlex
- W1988413525
- Cited by
- 283
- References
- 42
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.